和铂医药-B11月28日斥资133.7万港元回购10万股
Core Viewpoint - The company, Heptagon Pharmaceuticals-B (02142), announced a share buyback plan, indicating confidence in its stock value and future prospects [1] Group 1: Share Buyback Details - The company will repurchase 100,000 shares at a total cost of HKD 1.337 million [1] - The buyback price per share ranges from HKD 13.18 to HKD 13.53 [1]